|Articles|April 1, 2020
PHARMASEAL Offering No Cost CTMS for COVID-19 Clinical Trials
Advertisement
PHARMASEAL International has announced that it will offer the Engility CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The offer is open to biopharmaceutical organizations and academic institutions.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
